Glial fibrillary acidic protein (GFAP): purification from human fibrillary astrocytoma, development and validation of a radioimmunoassay for GFAP-like immunoactivity - PubMed (original) (raw)
Glial fibrillary acidic protein (GFAP): purification from human fibrillary astrocytoma, development and validation of a radioimmunoassay for GFAP-like immunoactivity
J W Palfreyman et al. J Neurol Sci. 1979 Mar.
Abstract
The extraction and purification of glial fibrillary acidic protein (GFAP) from human fibrillary cerebellar astrocytoma is described. Using an immunoperoxidase method, antisera raised to the protein showed specific staining of astrocytes in normal spinal cord and in tumours of astrocytic origin. A double antibody radioimmunoassay for GFAP in tissue extract was developed, the detection limit of the assay being 360 pg. Extracts of tissues other than brain or spinal cord did not cross-react significantly in the assay, neither did purified preparations of myelin basic and S-100 proteins. Levels of GFAP in normal CNS tissue were higest in spinal cord (1370 microgram/g wet weight) but a level of 3050 microgram/g wet weight was detected in a fibrillary astrocytoma.
Similar articles
- Do Rosenthal fibers contain glial fibrillary acid protein?
Janzer RC, Friede RL. Janzer RC, et al. Acta Neuropathol. 1981;55(1):75-6. doi: 10.1007/BF00691535. Acta Neuropathol. 1981. PMID: 7348009 - Rosenthal fibres are based on the ubiquitination of glial filaments.
Lowe J, Morrell K, Lennox G, Landon M, Mayer RJ. Lowe J, et al. Neuropathol Appl Neurobiol. 1989 Jan-Feb;15(1):45-53. doi: 10.1111/j.1365-2990.1989.tb01148.x. Neuropathol Appl Neurobiol. 1989. PMID: 2542826 - [Immunohistochemical studies of hemangioblastoma with glial fibrillary acidic protein].
Mannoji H, Takeshita I, Fukui M, Kitamura K. Mannoji H, et al. No To Shinkei. 1983 Dec;35(12):1207-16. No To Shinkei. 1983. PMID: 6367779 Japanese. - The ultrastructure of glial tumors of astrocytic lineage: a review.
Liberski PP. Liberski PP. Folia Neuropathol. 1998;36(3):161-77. Folia Neuropathol. 1998. PMID: 9833393 Review. - Role of glial filaments in cells and tumors of glial origin: a review.
Rutka JT, Murakami M, Dirks PB, Hubbard SL, Becker LE, Fukuyama K, Jung S, Tsugu A, Matsuzawa K. Rutka JT, et al. J Neurosurg. 1997 Sep;87(3):420-30. doi: 10.3171/jns.1997.87.3.0420. J Neurosurg. 1997. PMID: 9285609 Review.
Cited by
- GFAP expression as an indicator of disease severity in mouse models of Alexander disease.
Jany PL, Hagemann TL, Messing A. Jany PL, et al. ASN Neuro. 2013;5(1):e00109. doi: 10.1042/AN20130003. ASN Neuro. 2013. PMID: 23432455 Free PMC article. - Interrelationship between differentiation and malignancy-associated properties in glioma.
Frame MC, Freshney RI, Vaughan PF, Graham DI, Shaw R. Frame MC, et al. Br J Cancer. 1984 Mar;49(3):269-80. doi: 10.1038/bjc.1984.44. Br J Cancer. 1984. PMID: 6200130 Free PMC article. - Neuropeptides in neurological tumours.
Allen JM, Hoyle NR, Yeats JC, Ghatei MA, Thomas DG, Bloom SR. Allen JM, et al. J Neurooncol. 1985;3(3):197-202. doi: 10.1007/BF00165179. J Neurooncol. 1985. PMID: 2414412 - Clinically viable magnetic poly(lactide-co-glycolide) particles for MRI-based cell tracking.
Granot D, Nkansah MK, Bennewitz MF, Tang KS, Markakis EA, Shapiro EM. Granot D, et al. Magn Reson Med. 2014 Mar;71(3):1238-50. doi: 10.1002/mrm.24741. Magn Reson Med. 2014. PMID: 23568825 Free PMC article. - Spinal cord injury elicits expression of keratan sulfate proteoglycans by macrophages, reactive microglia, and oligodendrocyte progenitors.
Jones LL, Tuszynski MH. Jones LL, et al. J Neurosci. 2002 Jun 1;22(11):4611-24. doi: 10.1523/JNEUROSCI.22-11-04611.2002. J Neurosci. 2002. PMID: 12040068 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous